Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by DDobbson Jan 17, 2018 10:18am
197 Views
Post# 27375969

RE:ACB SP without CMED

RE:ACB SP without CMEDLets start with what we know for sure.....CMED has 18% voting no for sure and needs 33.3% to vote no.  Now I am not to sure if CMED needs 50.1% to aquire hip or 66.3 as ACB needs to get CMED.  

So lets assume they need 50.1 then I think that fails and we needs 66.3% so that may fail to which means both outcomes can fail.

If this happens then CMED and ACB will have to negotiate a better deal or ACB can choose to walk away.  Now lets assume ACB sweetens the deal.  Their share price could dip for over paying CMED if the market views it as such.  I know I would, I dont think CMED is worth more than 24 and if they have to pay over 30 bucks I would run away from this deal, not worth the 40,000 patients with recreatipon use right around the corner.  

Now if ACB walks away they may slip a little to say 10 bucks short term and bounce back.  No long term affect here.

If CMED doesnt vote yes for ACB I hope ACB walks away.  CMED has not negotiated with them, they are acting like a bunch of crazies who think they are valued at 60 bucks.  There are plenty of fish in the sea to catch and ACB will just find another dance partner.....
Bullboard Posts